Figure 3
Evaluation of both tumor volume and perfusion from B16F10-xenografted
mice treated with mice anti-PD1 or PBS. (A) Evaluation of tumor
perfusion through contrast enhanced ultrasonography (CEUS) at the
beginning of treatment and one week after. (B) Tumor perfusion was
measured by laser speckle contrast imaging at the beginning of treatment
and one week after. Data are expressed as the mean ± SEM.
Kruskal–Wallis test followed by a Dunn’s post hoc test (ns
p>0.05).